Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of blimp-1 and bcl-61

被引:531
作者
Ozaki, K
Spolski, R
Ettinger, R
Kim, HP
Wang, G
Qi, CF
Hwu, P
Shaffer, DJ
Akilesh, S
Roopenian, DC
Morse, HC
Lipsky, PE
Leonard, WJ
机构
[1] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA
[2] NIAMSD, Autoimmun Branch, NIH, Bethesda, MD 20892 USA
[3] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA
[4] NIAID, Immunopathol Lab, NIH, Bethesda, MD 20892 USA
[5] Jackson Lab, Bar Harbor, ME 04609 USA
关键词
D O I
10.4049/jimmunol.173.9.5361
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-21 is a type I cytokine whose receptor is expressed on T, B, and NK cells. Within the B cell lineage, IL-21 regulates IgG1 production and cooperates with IL-4 for the production of multiple Ab classes in vivo. Using IL-21-transgenic mice and hydrodynamics-based gene delivery of IL-21 plasmid DNA into wild-type mice as well as in vitro studies, we demonstrate that although IL-21 induces death of resting B cells, it promotes differentiation of B cells into postswitch and plasma cells. Thus, IL-21 differentially influences B cell fate depending on the signaling context, explaining how IL-21 can be proapoptotic for B cells in vitro yet critical for Ag-specific Ig production in vivo. Moreover, we demonstrate that IL-21 unexpectedly induces expression of both Blimp-1 and Bcl-6, indicating mechanisms as to how IL-21 can serve as a complex regulator of B cell maturation and terminal differentiation. Finally, BXSB-Yaa mice, which develop a systemic lupus erythematosus-like disease, have greatly elevated IL-21, suggesting a role for IL-21 in the development of autoimmune disease.
引用
收藏
页码:5361 / 5371
页数:11
相关论文
共 33 条
[1]   Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis [J].
Akilesh, S ;
Shaffer, DJ ;
Roopenian, D .
GENOME RESEARCH, 2003, 13 (07) :1719-1727
[2]   Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation [J].
Allman, D ;
Lindsley, RC ;
DeMuth, W ;
Rudd, K ;
Shinton, SA ;
Hardy, RR .
JOURNAL OF IMMUNOLOGY, 2001, 167 (12) :6834-6840
[3]   Cutting edge:: The common γ-chain is an indispensable subunit of the IL-21 receptor complex [J].
Asao, H ;
Okuyama, C ;
Kumaki, S ;
Ishii, N ;
Tsuchiya, S ;
Foster, D ;
Sugamura, K .
JOURNAL OF IMMUNOLOGY, 2001, 167 (01) :1-5
[4]   Interleukin-21 is a growth and survival factor for human myeloma cells [J].
Brenne, AT ;
Ro, TB ;
Waage, A ;
Sundan, A ;
Borset, M ;
Hjorth-Hansen, H .
BLOOD, 2002, 99 (10) :3756-3762
[5]   Regulatory mechanisms that determine the development and function of plasma cells [J].
Calame, KL ;
Lin, KI ;
Tunyaplin, C .
ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 :205-230
[6]   Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function [J].
Gorelik, L ;
Cutler, AH ;
Thill, G ;
Miklasz, SD ;
Shea, DE ;
Ambrose, C ;
Bixler, SA ;
Su, LH ;
Scott, ML ;
Kalled, SL .
JOURNAL OF IMMUNOLOGY, 2004, 172 (02) :762-766
[7]   Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow [J].
Hao, ZY ;
Rajewsky, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (08) :1151-1163
[8]   Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection [J].
Held, W ;
Cado, D ;
Raulet, DH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (05) :2037-2041
[9]   IL-21 limits NK cell responses and promotes antigen-specific T cell activation: A mediator of the transition from innate to adaptive immunity [J].
Kasaian, MT ;
Whitters, MJ ;
Carter, LL ;
Lowe, LD ;
Jussif, JM ;
Deng, BJ ;
Johnson, KA ;
Witek, JS ;
Senices, M ;
Konz, RF ;
Wurster, AL ;
Donaldson, DD ;
Collins, M ;
Young, DA ;
Grusby, MJ .
IMMUNITY, 2002, 16 (04) :559-569
[10]   Homeostatic expansion of T cells during immune insufficiency generates autoimmunity [J].
King, C ;
Ilic, A ;
Koelsch, K ;
Sarvetnick, N .
CELL, 2004, 117 (02) :265-277